Tara McElroy, DPM
Podiatrist · Winston Salem, NCNPI 1780266395
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Stryker at 34.0% of the total. Reporting peaked in 2024 at $3,335 and has fallen 91.1% since, to $298 in 2025.
Across 54 payments — averaging $91.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Supreme Orthopedic Systems, LLC$1K
- Piedmont Plus Innovation$772
- Arthrex$412
- Treace Medical Concepts, Inc.$217
- Biocomposites Inc$173
- plus $473 from 10 others
What the payments were for
- Travel & lodging$1,76536%
- Food & beverage$1,98840%
- Education$1,20024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 19 | $1,686 |
| Supreme Orthopedic Systems, LLC | 2 | $1,220 |
| Piedmont Plus Innovation | 5 | $772 |
| Arthrex | 11 | $412 |
| Treace Medical Concepts, Inc. | 2 | $217 |
| Biocomposites Inc | 2 | $173 |
| Integra Lifesciences Corporation | 4 | $166 |
| Fortis Surgical, LLC | 1 | $86 |
| Exactech, Inc. | 1 | $52 |
| Acera Surgical, Inc. | 1 | $42 |
| Boston Scientific | 1 | $27 |
| Acumed LLC | 1 | $24 |
| AbbVie | 1 | $22 |
| Smith+Nephew | 1 | $19 |
| Solventum Corporation | 1 | $18 |
| Lifenet Health | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORTHOLOC 3DI$607
- ORTHOLOC 2 LAPIFUSE$370
- AXS INFINITY LS$171
- Stimulan$111
How this compares
$4,953 in reported general payments places this provider in the 75th percentile of 109 podiatrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 75 | $2,203 |
| Ammonium Lactate | 50 | $1,283 |
| Ketoconazole | 20 | $375 |
| Diclofenac Sodium | 11 | $285 |
| Doxycycline Hyclate | 37 | $262 |
| SsdSilver Sulfadiazine | 13 | $128 |
| Gabapentin | 15 | $127 |
| Silver Sulfadiazine | 15 | $96 |
| Meloxicam | 38 | $86 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Winston Salem
- Ashleigh MeddaWinston Salem$3K
- Jordan MeyersRaleigh$343K
- Christopher GaulandGreenville$56K
- Scott MartinRocky Mount$14K
- Gretchen LawrenceForest City$12K
- William WeilyCharlotte$11K
- Kristin KirbyHuntersville$10K
- Robert PrzynoschWaynesville$9K
- William BanksWaynesville$9K
- Emily LobosAsheville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.